Sponsor or institution

Clinical trials and research at TaiRx, Inc.

As of November 12, 2026, Find a Trial lists 3 clinical trials run by TaiRx, Inc. that are recruiting, at sites in 2 countries (most in Taiwan (2), China (1)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
CVM-1118 plus sintilimab infusions and TACE for incurable non-metastatic liver cancer Phase 2 Fuzhou, Fujian and 1 other locations Recruiting Apr 13, 2026
Testing TRX-920 Oral Gel for Advanced Solid Tumors Phase 1 Taichung and 2 other locations Recruiting Nov 22, 2023
CVM-1118 combined with Nivolumab for advanced liver cancer Phase 2 Kaohsiung City and 4 other locations Recruiting Feb 25, 2022

All recruiting trials (3)

Quick answers

How many clinical trials run by TaiRx, Inc. are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Taiwan (2 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.